INMB Q3 2017 Earnings — INmune Bio, Inc. Revenue & Financial Results | Market Cap Arena

INMBINmune Bio, Inc.

$38M

Q3 2017 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$308,000

Net Income

-$308,000

EPS (Diluted)

$-0.03

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$154,631

Free Cash Flow

-$154,631

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$2M

Total Liabilities

$191,537

Stockholders' Equity

$2M

Cash & Equivalents

$2M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$308,000	-$54,197	-468.3%
Net Income	-$308,000	-$54,197	-468.3%